NIH 2020 U01 CA |
Defining neoantigen immunodominance for antigen selection and biomarker discovery in human pancreatic cancer immunotherapy Balachandran, Vinod P.; Leach, Steven D. / Sloan-Kettering Institute for Cancer Research |
|
NIH 2017 U01 CA |
Defining neoantigen immunodominance for antigen selection and biomarker discovery in human pancreatic cancer immunotherapy Balachandran, Vinod P.; Leach, Steven D. / Sloan-Kettering Institute for Cancer Research |
|